A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
Clinical trial NCT06698042 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06698042
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2026-03-12
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.